Red light photodynamic therapy (PDT) with 10% aminolevulinic acid (ALA) tamed superficial basal cell carcinoma (BCC) in a phase 3 trial with no new safety concerns. Significantly higher clearance ...
Therapeutic activity requires a photosensitizer, wavelength-matched light, and tissue oxygen, generating ROS that induce apoptosis, vascular disruption, and immunomodulatory effects within targeted ...
Please provide your email address to receive an email when new articles are posted on . PDT with ALA works well in BCC treatment, but is limited by injection depth. Jet-injected PDT could be a viable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results